| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 01/25/2007 | US20070020260 Glycoprotein compositions |
| 01/25/2007 | US20070017513 Method and apparatus for dispensing inhalator medicament |
| 01/25/2007 | CA2790675A1 Inhibition of the tumorigenic potential of tumor stem cells by lif and bmps |
| 01/25/2007 | CA2657953A1 Alpha-synuclein antibodies and methods related thereto |
| 01/25/2007 | CA2616146A1 Compounds and their salts specific to the ppar receptors and the egf receptors and their use in the medical field |
| 01/25/2007 | CA2616008A1 Stabilized chlorite solutions in combination with fluoropyrimidines for cancer treatment. |
| 01/25/2007 | CA2615978A1 Compounds and their salts specific to the ppar receptors and the egf receptors and their use in the medical field |
| 01/25/2007 | CA2615752A1 Use of thiazole derivatives and analogues in the treatment of cancer |
| 01/25/2007 | CA2615744A1 Plexin d1 as a target for tumor diagnosis and therapy |
| 01/25/2007 | CA2615738A1 Bifunctional protein anchors |
| 01/25/2007 | CA2615596A1 Ethanolamine salt of n- (3-methoxy-5-methylpyrazin-2yl) -2- (4- [1 , 3 , 4-oxadiazole-2-yl] phenyl) pyridine-3- sulphonamide |
| 01/25/2007 | CA2615579A1 Combination comprising a pyrimidylaminobenzamides and a flt-3 inhibitor for treating proliferative diseases |
| 01/25/2007 | CA2615491A1 Inhibition of the tumorigenic potential of tumor stem cells by lif and bmps |
| 01/25/2007 | CA2615433A1 Pyrazolo[1.5-a]pyrimidin-7-yl amine derivatives as protein kinase inhibitors |
| 01/25/2007 | CA2615373A1 Quinazoline derivatives useful in cancer treatment |
| 01/25/2007 | CA2615254A1 Combinations of pyrimidylaminobenzamide bcr-abl inhibitors and mtor inhibitors for the treatment of leukemia |
| 01/25/2007 | CA2615112A1 Synthesis and complete stereochemical assignment of psymberin/irciniastatin for anti-tumor use |
| 01/25/2007 | CA2615105A1 Histone deacetylase inhibitors |
| 01/25/2007 | CA2614963A1 Spirochromanone derivatives as acetyl coenzyme a carboxylase (acc) inhibitors |
| 01/25/2007 | CA2614770A1 The use of inhibitors of histone deacetylases in combination with compounds acting as nsaid for the therapy of human diseases |
| 01/25/2007 | CA2614687A1 Use of aprotinin polypeptides as carriers in pharmaceutical conjugates |
| 01/25/2007 | CA2612468A1 4,5-dihydr0-1h-pyrazole derivatives, their preparation and use as medicaments |
| 01/25/2007 | CA2612459A1 New crystal forms of 4-[6-methoxy-7-(3-piperidin-1-yl-propoxy)quinazolin-4-yl]piperazine-1-carboxylic acid(4-isopropoxyphenyl)-amide |
| 01/25/2007 | CA2611366A1 Azepane- or azocane-substituted pyrazoline derivatives, their preparation and use as medicaments |
| 01/25/2007 | CA2611364A1 Indoline-substituted pyrazoline derivatives, their preparation and use as medicaments |
| 01/24/2007 | EP1746421A2 Diagnostic and therapeutic application of antibodies against the urokinase receptor |
| 01/24/2007 | EP1746160A2 Hepatocyte growth factor receptor antagonists and uses thereof |
| 01/24/2007 | EP1746159A2 Immunostimulatory nucleic acid molecules |
| 01/24/2007 | EP1746157A1 Method of proliferating plasma cell |
| 01/24/2007 | EP1746106A2 Use of TACI as an anti-tumor agent |
| 01/24/2007 | EP1746103A1 Bifunctional protein anchors |
| 01/24/2007 | EP1746100A1 Annelated carbamoylase-heterocycles, focused library, pharmaceutical compositions and methods for the production thereof |
| 01/24/2007 | EP1746096A1 2-Arylbenzothiazole analogues and uses thereof in the treatment of cancer |
| 01/24/2007 | EP1746093A1 Process for preparing substituted pyrimidines |
| 01/24/2007 | EP1746087A1 Derivates of 3-indolylmethylene having cytostatic properties |
| 01/24/2007 | EP1746086A1 Cyanopyrrolidine derivatives |
| 01/24/2007 | EP1745801A1 Method of inhibiting telomerase activity and inhibitor |
| 01/24/2007 | EP1745800A1 Novel blt2-mediated disease, and blt2 binding agent and compound |
| 01/24/2007 | EP1745799A2 Compositions and methods of treating tumors |
| 01/24/2007 | EP1745797A2 Vascularization inhibitors |
| 01/24/2007 | EP1745796A1 Compound preparation for treating prostate carcinoma |
| 01/24/2007 | EP1745788A1 Acyglycerophospholipids for treating cancer and cachexia |
| 01/24/2007 | EP1745787A2 Non-calcemic, antiproliferative, transcriptionally active sulfur-containing analogs of 1-alpha 25-dihydroxy Vitamin D3 |
| 01/24/2007 | EP1745780A1 Medicinal preparation |
| 01/24/2007 | EP1745779A2 Uses of perfluorinated carboylic acid derivatives for the manufacture of a medicament for the modulation of body mass |
| 01/24/2007 | EP1745071A2 Msh-agonist tripeptide conjugates |
| 01/24/2007 | EP1745050A1 Thienopyridines as ikk inhibitors |
| 01/24/2007 | EP1745044A2 Benzothiazole derivatives having cdk modulating activity and use thereof as anticancer agents |
| 01/24/2007 | EP1745041A2 Quinoxaline inhibitors of the hedgehog signalling pathway |
| 01/24/2007 | EP1745032A2 Cxcr1 and cxcr2 chemokine antagonists |
| 01/24/2007 | EP1744789A1 Activatable particles, preparations and uses |
| 01/24/2007 | EP1744744A2 Bioactive compounds and methods of uses thereof |
| 01/24/2007 | EP1744741A2 Coadministration of radiation, efaproxiral sodium, and supplemental oxygen for the treatment of cancer |
| 01/24/2007 | EP1667992B1 Quinazoline derivatives |
| 01/24/2007 | EP1615640B1 Antineoplastic combinations |
| 01/24/2007 | EP1503714A4 Low profile combination device for gastrostomy or jejunostomy applications having anti-granuloma formation characteristics |
| 01/24/2007 | EP1448236B1 Inclusion complex of taxol with 2-hxdroxypropyl-beta-cyclodextrin |
| 01/24/2007 | EP1443967B1 Cyclooxygenase-2 inhibitor/histone deacetylase inhibitor combination |
| 01/24/2007 | EP1408939A4 Methods for preparation and use of 1 alpha,24(s)-dihydroxyvitamin d2 |
| 01/24/2007 | EP1390405B1 Preparation of cholecystokinin agonists and antagonists and their therapeutic and diagnostic use |
| 01/24/2007 | EP1363900B1 Isoindole-imide compounds, compositions and uses thereof |
| 01/24/2007 | EP1341537B1 Pharmaceutically active isoindoline derivatives |
| 01/24/2007 | EP1276501B9 Method for treatment of tumors using photodynamic therapy |
| 01/24/2007 | EP1265920B9 Angiogenesis-associated proteins, and nucleic acids encoding the same |
| 01/24/2007 | EP1257285B1 Use of breast cancer associated membrane proteins (bcmp) for treatment, prophylaxis and diagnosis of breast cancer |
| 01/24/2007 | EP1181363B1 Recombinant human mannan-binding lectin |
| 01/24/2007 | EP1123414B1 Antisense modulation of integrin alpha 4 expression |
| 01/24/2007 | EP1100507B1 Use of a combination comprising a precursor of uric acid and antioxidant for the treatment of neurodegenerative deseases |
| 01/24/2007 | EP1067908B9 Taxane microemulsions |
| 01/24/2007 | EP0970213B1 Death domain containing receptor 5 |
| 01/24/2007 | EP0968206B8 N-heterocyclic derivatives as nos inhibitors |
| 01/24/2007 | EP0760000B1 Alphavirus expression vector |
| 01/24/2007 | CN1902488A Screening assays and methods of tumor treatment |
| 01/24/2007 | CN1902313A Wt1-origin HLA-DR-binding antigen peptide |
| 01/24/2007 | CN1902312A Method of constructing transgenic dendritic cell |
| 01/24/2007 | CN1902214A Cobalamine derivatives useful for diagnosis and treatment of abnormal cellular proliferation |
| 01/24/2007 | CN1902200A 1h-imidazoquinoline derivatives as protein kinase inhibitors |
| 01/24/2007 | CN1902193A Quinoxalines useful as inhibitors of protein kinases |
| 01/24/2007 | CN1902190A 2-(hetero-)aryl substituted tetrahydroquinoline derivatives |
| 01/24/2007 | CN1902185A Thiazolidinones, their production and use as pharmaceutical agents |
| 01/24/2007 | CN1902159A Novel nitrophenyl mustard and nitrophenylaziridine alcohols and their corresponding phosphates and their use as targeted cytotoxic agents |
| 01/24/2007 | CN1902156A Jasmonate derivative compounds, pharmaceuticals compositions and methods of use thereof |
| 01/24/2007 | CN1901939A Treatment of proliferative diseases using an antisense IAP oligomer and chemotherapeutic agent |
| 01/24/2007 | CN1901937A Use of antagonist anti-cd40 antibodies for treatment of chronic lymphocytic leukemia |
| 01/24/2007 | CN1901906A Cci-779 for treating mantle cell lymphoma |
| 01/24/2007 | CN1900292A Solid fermenting method for vitacoenzyme medicine |
| 01/24/2007 | CN1900279A Polynucleotide for inducing apoptosis and its coded polypeptide and use |
| 01/24/2007 | CN1900119A Staphylococcus aureus enterotoxin 1 and preparation and use |
| 01/24/2007 | CN1900118A No-adjuvant therapeutic protein vaccine containing heat shock protein and HPV 16Z protein antigen |
| 01/24/2007 | CN1900117A Humanized CTLA-4 single chain antibody and human perforin path formed peptide P34 recombinant immunotoxin |
| 01/24/2007 | CN1900116A Anti-lymphotoxin-beta receptor antibodies, pharmaceutical composition containing the same and pharmaceutical application thereof |
| 01/24/2007 | CN1900110A Octreotide allosteric peptide molecule and its medicine |
| 01/24/2007 | CN1900105A Compound with anti-tumor activity and its preparing method |
| 01/24/2007 | CN1900094A Organic platinum new complex |
| 01/24/2007 | CN1900079A New imidazole derivative, method for producing the same and use of the same |
| 01/24/2007 | CN1900074A Substituted oxazolidinones and their use in the field of blood coagulation |
| 01/24/2007 | CN1899622A Applying method for using magnetic field in magnetic particles |
| 01/24/2007 | CN1899616A New use of non-receptor tyrosine kinase c-Ab1 specific inhibitor |
| 01/24/2007 | CN1899615A Preparation for the prophylaxis of restenose |
| 01/24/2007 | CN1899614A Preparation for the prophylaxis of restenose |